Efficacy of Estrogen Therapy in Patients With Intrauterine Adhesions: Systematic Review

Journal of Minimally Invasive Gynecology

Volumn 21, Issue 1, 2014, Pages 44-54

  Johary, Jolinda ^a   Xue, Min ^a   Zhu, Xiaogang ^a   Xu, Dabao ^a   Velu, Prasad Palani ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b The Collaborative Research   (Australia)

Author keywords

Endometrium; Estrogen therapy; Hysteroscopy; Intrauterine adhesions; Repeat adhesions

Indexed keywords

ESTROGEN; HYALURONIC ACID;

DRUG EFFICACY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FOLEY BALLOON CATHETER; HIGH RISK PATIENT; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIVE BIRTH; MENSTRUATION; PREGNANCY; REVIEW; SYSTEMATIC REVIEW; UTERUS SYNECHIA;

ENDOMETRIUM; ESTROGEN THERAPY; HYSTEROSCOPY; INTRAUTERINE ADHESIONS; REPEAT ADHESIONS;

COMBINED MODALITY THERAPY; ESTROGENS; FEMALE; HUMANS; HYSTEROSCOPY; INTRAUTERINE DEVICES; TISSUE ADHESIONS; TREATMENT OUTCOME; UTERINE DISEASES;

EID: 84891149487     PISSN: 15534650     EISSN: 15534669     Source Type: Journal    
DOI: 10.1016/j.jmig.2013.07.018     Document Type: Review

References (72)

1. Yu D., Wong Y.M., Cheong Y., Xia E., Li T.C. Asherman syndrome: one century later. Fertil Steril 2008, 89:759-779.
2. Panayotidis C., Weyers S., Bosteels J.B., van Herendael B. Intrauterine adhesions (IUA): has there been progress in understanding and treatment over the last 20 yearsα. Gynecol Surg 2009, 6:197-211.
3. Magos A. Hysteroscopic treatment of Asherman's syndrome. Reprod Biomed Online 2002, 4(Suppl 3):46-51.
4. Deans R., Abbott J. Review of intrauterine adhesions. J Minim Invasive Gynecol 2010, 17:555-569.
5. Capella-Allouc S., Morsad F., Rongières-Bertrand C., Taylor S., Fernandez H. Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility. Hum Reprod 1999, 14:1230-1233.
6. Roge P., D'Ercole C., Cravello L., Boubli L., Blanc B. Hysteroscopic management of uterine synechiae: a series of 102 observations. Eur J Obstet Gynecol Reprod Biol 1996, 65:189-193.
7. Fernandez H., Al-Najjar F., Chauveaud-Lambling A., Frydman R., Gervaise A. Fertility after treatment of Asherman's syndrome stage 3 and 4. J Minim Invasive Gynecol 2006, 13:398-402.
8. Thomson A.J., Abbott J.A., Kingston A., Lenart M., Vancaille T.G. Fluoroscopically guided synechiolysis for patients with Asherman's syndrome: menstrual and fertility outcomes. Fertil Steril 2007, 87:405-410.
9. Malhotra N., Bahadur A., Kalaivani M., Mittal S. Changes in endometrial receptivity in women with Asherman's syndrome undergoing hysteroscopic adhesiolysis. Arch Gynecol Obstet 2012, 286:525-530.
10. Robinson J.K., Colimon L.M., Isaacson K.B. Postoperative adhesiolysis therapy for intrauterine adhesions (Asherman's syndrome). Fertil Steril 2008, 90:409-414.
11. Protopapas A., Shushan A., Magos A. Myometrial scoring: a new technique for the management of severe Asherman's syndrome. Fertil Steril 1998, 69:860-864.
12. Orhue A.A., Aziken M.E., Igbefoh J.O. A comparison of two adjunctive treatments for intrauterine adhesions following lysis. Int J Gynaecol Obstet 2003, 82:49-56.
13. Zikopoulos K.A., Kolibianakis E.M., Platteau P., et al. Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online 2004, 8:720-725.
14. Amer M.I., Abd-El-Maeboud K.H. Amnion graft following hysteroscopic lysis of intrauterine adhesions. J Obstet Gynaecol Res 2006, 32:559-566.
15. Pabuccu R., Onalan G., Kaya C., et al. Efficiency and pregnancy outcome of serial intrauterine device-guided hysteroscopic adhesiolysis of intrauterine synechiae. Fertil Steril 2008, 90:1973-1977.
16. Yu D., Li T.C., Xia E., Huang X., Liu Y., Peng X. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome. Fertil Steril 2008, 89:715-722.
17. Dawood A., Al-Talib A., Tulandi T. Predisposing factors and treatment outcome of different stages of intrauterine adhesions. J Obstet Gynaecol Can 2010, 32:767-770.
18. Roy K.K., Baruah J., Sharma J.B., Kumar S., Kachawa G., Singh N. Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due to Asherman's syndrome. Arch Gynecol Obstet 2010, 281:355-361.
19. Feng Z.C., Yang B., Shao J., Liu S. Diagnostic and therapeutic hysteroscopy for traumatic intrauterine adhesions after induced abortions: clinical analysis of 365 cases. Gynaecol Endosc 1999, 8:95-98.
20. Fumino T., Teranishi A., Wakimoto E., Hamai H., Kuwata A., Shigata M. Early second-look flexible hysteroscopy is effective for the treatment of Asherman's syndrome. Fertil Steril 2007, 88(Suppl 1):S224.
21. Fernandez H., Peyrelevade S., Legendre G., Faivre E., Deffieux X. Total adhesions treated by hysteroscopy: must we stop at two proceduresα. Fertil Steril 2012, 98:980-985.
22. Coccia M.E., Becattii C., Bracco G.L., Pampaloni F., Bargelli G., Scarselli G. Pressure lavage under ultrasound guidance: a new approach for outpatient treatment of intrauterine adhesions. Fertil Steril 2001, 75:601-606.
23. Caspi E., Perpineal S. Reproductive performance after treatment of intrauterine adhesions. Int J Fertil 1975, 20:249.
24. March C.M., Israel R. Intrauterine adhesions secondary to elective abortion: hysteroscopic diagnosis and management. Obstet Gynecol 1976, 48:422-424.
25. Chen F.P., Soong Y.K., Hui Y.L. Successful treatment of severe uterine synechiae with transcervical resectoscopy combined with laminaria tent. Hum Reprod 1997, 12:943-947.
26. Pabuccu R., Atay V., Orhon E., Urman B., Ergün A. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertil Steril 1997, 68:1141-1143.
27. Ozumba B., Ezegwui H. Intrauterine adhesions in an African population. Int J Gynaecol Obstet 2002, 77:37-38.
28. Cohen J., Copperman A.B. Value of 3D ultrasound in the management of suspected Asherman's syndrome. J Reprod Med 2007, 52:1016-1022.
29. Palter S.F. Highly successful treatment algorithm for Asherman's syndrome. Fertil Steril 2005, 84:S470.
30. Yasmin H., Nasir A., Noorani K.J. Hystroscopic management of Asherman's syndrome. J Pak Med Assoc 2007, 57:553-555.
31. Salma U., Xu D., Ali Sheikh S. Observational study of new treatment proposal for severe intrauterine adhesion. Int J Biosci 2011, 1:43-56.
32. Myers E.M., Hurst B.S. Comprehensive management of severe Asherman syndrome and amenorrhea. Fertil Steril 2012, 97:160-164.
33. Slayden O.D., Brenner R.M. RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 1994, 78:440-448.
34. Okulicz W.C., Scarrell R. Estrogen receptor alpha and progesterone receptor in the rhesus endometrium during the late secretory phase and menses. Proc Soc Exp Biol Med 1998, 218:316-321.
35. Garcia E., Bouchard P., De Brux J., et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab 1988, 67:80-87.
36. Iruela-Arispe M.L., Rodriguez-Manzaneque J.C., Abu-Jawdeh G. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors. Microcirculation 1999, 6:127-140.
37. Charnock-Jones D.S., Sharkey A.M., Rajput-Williams J., et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993, 48:1120-1128.
38. Ferriani R.A., Charnock-Jones D.S., Prentice A., Thomas E.J., Smith S.K. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum Reprod 1993, 8:11-16.
39. Shifren J.L., Tseng J.F., Zaloudek C.J., et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996, 81:3112-3118.
40. Arici A., MacDonald P.C., Casey M.L. Modulation of the levels of transforming growth factor beta messenger ribonucleic acids in human endometrial stromal cells. Biol Reprod 1996, 54:463-469.
41. Itoh H., Kishore A.H., Lindqvist A., Rogers D.E., Word R.A. Transforming growth factor β1 (TGFβ1) and progesterone regulate matrix metalloproteinases (MMP) in human endometrial stromal cells. J Clin Endocrinol Metab 2012, 97:E888-E897.
42. Nayak N.R., Brenner R.M. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. JClin Endocrinol Metab 2002, 87:1845-1855.
43. Niklaus A.L., Aberdeen G.W., Babischkin J.S., Pepe G.J., Albrecht E.D. Effect of estrogen on vascular endothelial growth/permeability factor expression by glandular epithelial and stromal cells in the baboon endometrium. Biol Reprod 2003, 68:1997-2004.
44. Hyder S.M., Huang J.C., Nawaz Z., et al. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect 2000, 108(Suppl 5):785-790.
45. Sugino N., Kashida S., Karube-Harada A., Takiguchi S., Kato H. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 2002, 123:379-387.
46. Albrecht E.D., Babischkin J.S., Lidor Y., Anderson L.D., Udoff L.C., Pepe G.J. Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod 2003, 18:2039-2047.
47. Okada H., Tsutsumi A., Imai M., Nakajima T., Yasuda K., Kanzaki H. Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells. Fertil Steril 2010, 93:2680-2686.
48. Miwa I., Tamura H., Takasaki A., Yamagata Y., Shimamura K., Sugino N. Pathophysiologic features of "thin" endometrium. Fertil Steril 2009, 91:998-1004.
49. Heryanto B., Rogers P.A. Regulation of endometrial endothelial cell proliferation by oestrogen and progesterone in the ovariectomized mouse. Reproduction 2002, 123:107-113.
50. Zeyneloglu H.B., Seli E., Senturk L.M., Gutierrez L.S., Olive D.L., Arici A. The effect of monocyte chemotactic protein 1 in intraperitoneal adhesion formation in a mouse model. Am J Obstet Gynecol 1998, 179:438-443.
51. Howes E.L., Harwey S.C. The strength of the healing wound in relation to the holding strength of the chromic catgut suture. N Engl J Med 1929, 200:1285-1291.
52. Yang J.H., Chen M.J., Wu M.Y., Chao K.H., Ho H.N., Yang Y.S. Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas. Fertil Steril 2008, 89:1254-1259.
53. Römer T., Schmidt T., Foth D. Pre- and postoperative hormonal treatment in patients with hysteroscopic surgery. Contrib Gynecol Obstet 2000, 20:1-12.
54. AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL Practice Report: practice guidelines for management of intrauterine synechiae. J Minim Invasive Gynecol 2010, 17:1-7.
55. Schenker J.G., Margalioth E.J. Intrauterine adhesions: an updated appraisal. Fertil Steril 1982, 37:593-610.
56. Wood J., Pena G. Treatment of traumatic uterine synechias. Int J Fertil 1964, 9:405-410.
57. Sanfilippo J.S., Fitzgerald M.R., Badawy S.Z., Nussbaum M.L., Yussman M.A. Asherman's syndrome: a comparison of therapeutic methods. J Reprod Med 1982, 27:328-330.
58. Farhi J., Bar-Hava I., Homburg R., Dicker D., Ben-Rafael Z. Induced regeneration of endometrium following curettage for abortion: a comparative study. Hum Reprod 1993, 8:1143-1144.
59. Goldenberg M., Schiff E., Achiron R., Lipitz S., Mashiach S. Managing residual trophoblastic tissue: hysteroscopy for directing curettage. J Reprod Med 1997, 42:26-28.
60. Cohen S.B., Kalter-Ferber A., Weisz B.S., et al. Hysteroscopy may be the method of choice for management of residual trophoblastic tissue. J Am Assoc Gynecol Laparosc 2001, 8:199-202.
61. Rein D.T., Schmidt T., Hess A.P., Volkmer A., Schöndorf T., Breidenbach M. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage. J Minim Invasive Gynecol 2011, 18:774-778.
62. March C.M. Management of Asherman's syndrome. Reprod Biomed Online 2011, 23:63-76.
63. Friedler S., Margalioth E.J., Kafka I., Yaffe H. Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy: a prospective study. Hum Reprod 1993, 8:442-444.
64. Massouras H.G. Intrauterine adhesions; a syndrome of the past with the use of Massouras duck's foot No. 2 intrauterine contraceptive device. Am J Obstet Gynecol 1973, 116:576-578.
65. Polishuk W.Z., Weinstein D. The Soichet intrauterine device in the treatment of intrauterine adhesions. Acta Eur Fertil 1976, 7:215-218.
66. Tsapanos V.S., Stathopoulou L.P., Papathanassopoulou V.S., Tzingounis V.A. The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae. J Biomed Mater Res 2002, 63:10-14.
67. Acunzo G., Guida M., Pellicano M., et al. Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective randomized, controlled study. Hum Reprod 2003, 18:1918-1921.
68. Westendorp I.C., Ankum W.M., Mol B.W., Vonk J. Prevalence of Asherman's syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod 1998, 13:3347-3350.
69. Ballagh S.A., Harris H.A., Demasio K. Is curettage needed for uncomplicated incomplete spontaneous abortionα. Am J Obstet Gynecol 1998, 179:1279-1282.
70. Trinder J., Brocklehurst P., Porter R., Read M., Vyas S., Smith L. Management of miscarriage: expectant, medical, or surgicalα Results of randomised controlled trial (Miscarriage Treatment [MIST] trial). BMJ 2006, 332:1235-1240.
71. Bukulmez O., Yarali H., Gurgan T. Total corporal synechiae due to tuberculosis carry a very poor prognosis following hysteroscopic synechialysis. Hum Reprod 1999, 14:1960-1961.
72. Sharma J.B., Roy K.K., Pushparaj M., et al. Genital tuberculosis: an important cause of Asherman's syndrome in India. Arch Gynecol Obstet 2008, 277:37-41.